1/63
A set of 60 vocabulary practice flashcards for the Adaptive Immunity – T cells lecture by Dr Chiara De Santi at RCSI, covering the development, selection, activation, effector subsets, tolerance, and immunodeficiencies of T cells.
Barrier Immunity
The body's instantaneous first line of defense consisting of physical, mechanical, and chemical barriers that impede pathogen entry.
Innate Immunity
The rapid immune defense responding within minutes to hours through cytokines, inflammation, the complement cascade, and antigen presentation.
Adaptive Immunity
The antigen-specific branch of the immune system that develops over days to weeks, mediated by cytotoxic and helper T cells as well as antibody-producing B cells.
Helper T Cells (Th)
CD4+ adaptive lymphocytes that orchestrate and support immune defenses by providing vital activating signals to B cells, macrophages, and other leukocytes.
Cytotoxic T Lymphocytes (CTL)
CD8+ effector T cells specialized in recognizing and directly destroying host cells infected by intracellular pathogens or transformed cancerous cells.

Antigen Presentation
The biological process wherein specialized cell surface receptors (MHC class I and MHC class II) display processed peptide antigens for recognition by T cell receptors.
MHC Class I
Cell surface molecules present on all nucleated cells (including epithelium, endothelium, and fibroblasts) that present intracellular peptide antigens to CD8+ cytotoxic T cells.
MHC Class II
Cell surface molecules expressed predominantly by specialized antigen-presenting cells that display extracellular peptide antigens specifically to CD4+ helper T cells.

T Cell Receptor (TCR)
A membrane-bound heterodimer composed of an alpha (α) and a beta (β) chain that specifically interacts with peptide antigens presented in complex with MHC molecules.
Variable (V) Region of TCR
The polymorphic extracellular antigen-binding domain located at the amino terminus of both the α and β chains of the TCR, unique to each individual T cell clone.
Constant (C) Region of TCR
The conserved structural region of the TCR chains that does not change between clones and connects the variable domain to the hinge and transmembrane anchor.
VDJ Recombination
The somatic DNA rearrangement mechanism operating during T cell development that randomly joins Variable (V), Diversity (D), and Joining (J) gene segments to generate unique TCR specificities.
TCR Alpha (α) Chain Locus
The genetic locus situated on chromosome 14, comprising approximately 45 V genes and 50 J genes that rearrange at the genomic DNA level.
TCR Beta (β) Chain Locus
The genetic locus located on chromosome 7, composed of approximately 50 V genes, 2 D genes, and 12 J genes rearranged during thymic maturation.
TCR Combinatorial Diversity
The capacity of somatic V(D)J gene recombination to generate up to 1014 distinct theoretical TCR combinations, allowing recognition of virtually any foreign antigen.
Thymus
The primary lymphoid organ where immature precursor T cells seeded from the bone marrow undergo maturation, receptor gene rearrangement, and developmental selection.
Thymocytes
Developing, immature T lymphocytes located within the thymus that progress through strict lineage-commitment and selection checkpoints.
Thymocyte Attrition Rate
The 98% proportion of developing thymocytes that fail positive or negative selection checkpoints and undergo apoptotic death inside the thymus.
T Cell Developmental Checkpoints
A trio of sequential developmental criteria: confirming expression of a functional TCR, successful self-MHC recognition (positive selection), and absence of strong self-reactivity (negative selection).
Double-Positive Thymocytes
Thymic precursor T cells that co-express both CD4 and CD8 surface co-receptors (CD4+CD8+) following initial successful TCR gene rearrangement.
Cluster of Differentiation (CD)
A standardized classification protocol used to designate specific cell surface molecules and receptors present on leukocytes.
Positive Selection
The survival checkpoint in the thymic cortex where double-positive thymocytes receive life signals upon successfully binding self-MHC molecules displayed on thymic epithelial cells.

Thymic Cortex
The outer anatomical zone of the thymus where developing thymocytes encounter thymic epithelial cells to undergo MHC restriction via positive selection.
Single-Positive Thymocytes
Differentiated thymocytes that have committed to either the CD4+ helper or CD8+ cytotoxic lineage depending on whether they engaged MHC class II or MHC class I during positive selection.
Negative Selection
The tolerance checkpoint in the thymic medulla whereby thymocytes that bind with high affinity to self-peptides presented on epithelial or dendritic cells are eliminated by apoptosis.

Thymic Medulla
The inner core of the thymus where single-positive thymocytes interact with self-peptides presented on thymic epithelial cells and dendritic cells to establish central tolerance.
Central Tolerance
The negative selection mechanism occurring within the primary generative lymphoid organ (thymus) that eliminates the majority of autoreactive T cell clones.
Naïve T Cells
Immunologically mature CD4+ or CD8+ T lymphocytes that have exited the thymus into circulation and secondary lymphoid organs but have never engaged their cognate foreign antigen.
Secondary Lymphoid Tissue
Peripheral organized structures, particularly lymph nodes, where naïve T cells encounter professional antigen-presenting cells to undergo initial priming and activation.
Three-Signal Model of T Cell Activation
The biological requirement for three consecutive cues to activate a naïve T cell: Signal 1 (antigen recognition), Signal 2 (co-stimulation), and Signal 3 (instructive cytokines).

Signal 1 (Antigen-Specific Interaction)
The foundational activation signal initiated by the specific engagement of the TCR and its associated CD4 or CD8 co-receptor with an MHC-peptide complex.
CD4 Co-Receptor
A surface glycoprotein that specifically binds invariant lateral domains of MHC class II molecules to stabilize the immunological synapse and recruit downstream intracellular signalling.
CD8 Co-Receptor
A cell surface glycoprotein that binds invariant domains of MHC class I molecules, assisting cytotoxic T cells in target recognition and activation.
Integrins (in T Cell Synapse)
Adhesion molecules present on T lymphocytes that bind counter-ligands on antigen-presenting cells to mechanically stabilize the immunological contact junction.
Signal 2 (Co-Stimulation)
The second compulsory activation signal mediated by microbial-induced co-stimulatory ligands on APCs that ensures lymphocyte survival, proliferation, and differentiation.
B7
A family of co-stimulatory surface ligands upregulated on antigen-presenting cells upon microbial exposure that binds to CD28 on naïve T cells.
CD28
A critical co-stimulatory surface receptor on T lymphocytes that binds B7 molecules on activated APCs to deliver the survival and proliferative Signal 2.
Signal 3 (Instructive Cytokines)
Cytokines released by activated antigen-presenting cells that guide and polarize the functional differentiation of primed CD4+ T cells into specialized helper subsets.
Interleukin-2 (IL-2)
A potent T cell growth factor synthesized rapidly following activation that drives clonal expansion in an autocrine fashion.
Autocrine Signalling (IL-2)
The physiological mechanism whereby an activated T cell produces IL-2 and simultaneously responds to it through high-affinity IL-2 receptors on its own cell surface.
Clonal Expansion
The rapid mitotic proliferation of an activated antigen-specific T cell clone into thousands of identical progeny dedicated to targeting that specific antigen.
Memory T Cells
A subset of differentiated, long-lived antigen-experienced T lymphocytes that persist in circulation for years to mount an accelerated, robust secondary immune response.
T Helper 1 (Th1) Subset
A CD4+ T cell effector lineage induced by IL-12 and IFN-γ that directs macrophage activation and cell-mediated defenses against intracellular bacteria and viruses.
Interleukin-12 (IL-12)
An instructive polarizing cytokine produced by activated APCs that instructs primed naïve CD4+ T cells to differentiate into Th1 effector cells.
Interferon-Gamma (IFN-γ)
The characteristic effector cytokine secreted by Th1 cells that stimulates macrophages and enhances cytotoxic T cell function against intracellular pathogens.
T Helper 2 (Th2) Subset
A CD4+ T cell lineage stimulated by IL-4 that coordinates host defenses against helminth parasitic worm infections and plays a central role in allergic responses.
Interleukin-4 (IL-4)
A cytokine that polarizes naïve CD4+ T cells toward the Th2 lineage and serves as an effector cytokine promoting antibody and antiparasitic responses.
Th2 Effector Cytokines (IL-4, IL-5, IL-13)
The effector cytokines released by Th2 cells that recruit and activate eosinophils, stimulate mast cells, and promote antibody production by B cells.
T Helper 17 (Th17) Subset
A CD4+ T helper lineage instructed by IL-23 that mediates inflammatory defenses against extracellular bacterial and yeast/fungal infections.
Interleukin-23 (IL-23)
An activating instructive cytokine synthesized by APCs that drives the differentiation and maintenance of the Th17 helper cell lineage.
Th17 Effector Cytokines (IL-17, IL-22)
Effector cytokines synthesized by Th17 lymphocytes that mobilize, recruit, and activate neutrophils to combat extracellular pathogens.
Perforin
A pore-forming cytolytic protein secreted from cytotoxic T cell lytic granules that integrates into the target cell plasma membrane to create transmembrane pores.
Granzymes
A family of cytotoxic serine proteases delivered from CTL lytic granules through perforin pores into target cells to trigger caspase cascades and induce programmed cell death.

T Cell Contraction / Homeostasis
The post-infection phase in which approximately 90% of effector T cells undergo apoptosis as foreign antigen, CD28 co-stimulation, and IL-2 levels decline.
CTLA-4
An inhibitory member of the CD28 receptor family that shuts down T cell activation signals to promote homeostatic contraction and tolerance.
PD-1
An inhibitory checkpoint receptor related to CD28 that antagonizes activation pathways to restrain T cell effector responses and prevent tissue damage.
Regulatory T Cells (Treg)
A specialized subset of CD4+ lymphocytes dedicated to dampening immune responses, maintaining self-tolerance, and inhibiting effector CD4 and CD8 T cells.
Interleukin-10 (IL-10)
A principal anti-inflammatory immunosuppressive cytokine secreted by regulatory T cells (Tregs) to down-modulate CD4 and CD8 T cell responses.
Self-Tolerance
A state of immunologic unresponsiveness to self-tissues and self-antigens maintained through central and peripheral tolerance mechanisms to prevent autoimmunity.
Peripheral Tolerance
Mechanisms (including functional anergy, apoptotic deletion, and Treg-mediated suppression) acting in peripheral tissues to silence autoreactive T cells that survived thymic selection.
Autoimmunity
A pathological state that arises when central and peripheral self-tolerance fails, enabling autoreactive T cells to attack normal host tissues in diseases such as rheumatoid arthritis, multiple sclerosis, and IBD.
Immunodeficiency
A broad umbrella term describing clinical conditions where elements of the immune system (such as lymphocytes, phagocytes, or complement) are defective or absent, leading to increased susceptibility to infections.
DiGeorge Syndrome
A primary immunodeficiency characterized by defective embryonic development of the thymus, leading to severe deficiency in T cell maturation and adaptive immunity.
Severe Combined Immunodeficiency (SCID)
A life-threatening primary immunodeficiency condition characterized by the severe absence or functional disruption of both T and B lymphocytes, leaving individuals unable to combat infections.